This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
earnings-growth: Archive
Wall Street Analysts See Cardinal (CAH) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Cardinal (CAH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CAHPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Bulls Look Optimistic About AudioEye (AEYE): Should You Buy?
by Zacks Equity Research
The average brokerage recommendation (ABR) for AudioEye (AEYE) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AEYEPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Here is Why Growth Investors Should Buy Credicorp (BAP) Now
by Zacks Equity Research
Credicorp (BAP) could produce exceptional returns because of its solid growth attributes.
BAPPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Wabtec (WAB)
by Zacks Equity Research
Wabtec (WAB) could produce exceptional returns because of its solid growth attributes.
WABPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Philip Morris (PM)
by Zacks Equity Research
Philip Morris (PM) possesses solid growth attributes, which could help it handily outperform the market.
PMNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Harmony Biosciences (HRMY)
by Zacks Equity Research
Harmony Biosciences (HRMY) possesses solid growth attributes, which could help it handily outperform the market.
HRMYNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Enova International (ENVA)
by Zacks Equity Research
Enova International (ENVA) could produce exceptional returns because of its solid growth attributes.
ENVAPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Looking for a Growth Stock? 3 Reasons Why Amphenol (APH) is a Solid Choice
by Zacks Equity Research
Amphenol (APH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
APHNegative Net Change
earnings-growth growth-investing growth-investors growth-stocks
3 Reasons Why Growth Investors Shouldn't Overlook Construction Partners (ROAD)
by Zacks Equity Research
Construction Partners (ROAD) could produce exceptional returns because of its solid growth attributes.
ROADPositive Net Change
earnings-growth growth-investing growth-investors growth-stocks
Wall Street Analysts Think New Gold (NGD) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in New Gold (NGD). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
NGDPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth